3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Completed
6
Terminated
2
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
2
Conditions
Polycythemia Vera
2
Thrombosis
1
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Hodgkin Disease
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Bites and Stings
1
Adenocarcinoma Of Esophagus
1
Interventions
fludarabine phosphate
5
Cyclophosphamide
4
Whole-Body Irradiation
3
Cyclosporine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
fludarabine
2
Stem Cell Transplantation
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Methylprednisolone
2
Hydroxyurea
2
Busulfan
2
Antilymphocyte Serum
2
ruxolitinib
1
nelarabine
1
fresolimumab
1
arsenous acid
1
Watchful Waiting
1
Thiotepa
1
Tetradecanoylphorbol Acetate
1
Surveys and Questionnaires
1
RG7388
1
Phlebotomy
1
Oxycodone
1
Observation
1
Nivolumab
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Moxifloxacin
1
Morphine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Polycythemia Vera
×
Hydroxyurea
×
Clear all
NCT05853458
2026-04-30
HU-F-AIM
Novartis
Phase 4
Terminated
76 enrolled
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled